Drug Profile
SLV 314
Alternative Names: SLV-314Latest Information Update: 17 Aug 2009
Price :
$50
*
At a glance
- Originator Solvay
- Class Antipsychotics; Benzoxazines; Indoles
- Mechanism of Action Dopamine D2 receptor antagonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bipolar disorders; Schizophrenia
Most Recent Events
- 05 Mar 2007 Phase-I clinical trials in Bipolar disorders in USA (PO)
- 05 Mar 2007 Phase-I clinical trials in Schizophrenia in European Union (PO)
- 05 Mar 2007 Phase-I clinical trials in Schizophrenia in USA (PO)